225 related articles for article (PubMed ID: 26476230)
61. Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers.
Iervolino S; Di Minno MN; Peluso R; Lofrano M; Russolillo A; Di Minno G; Scarpa R
J Rheumatol; 2012 Mar; 39(3):568-73. PubMed ID: 22247361
[TBL] [Abstract][Full Text] [Related]
62. Managing psoriatic arthritis in different clinical scenarios.
Queiro R; Loredo M; Braña I; Pardo E; Alonso S; Alperi M
Expert Rev Clin Immunol; 2023; 19(12):1469-1484. PubMed ID: 37589128
[TBL] [Abstract][Full Text] [Related]
63. Psoriatic Arthritis: Newer and Older Therapies.
Chao R; Kavanaugh A
Curr Rheumatol Rep; 2019 Dec; 21(12):75. PubMed ID: 31865449
[TBL] [Abstract][Full Text] [Related]
64. An overview of psoriatic arthritis - epidemiology, clinical features, pathophysiology and novel treatment targets.
Kerschbaumer A; Fenzl KH; Erlacher L; Aletaha D
Wien Klin Wochenschr; 2016 Nov; 128(21-22):791-795. PubMed ID: 27822746
[TBL] [Abstract][Full Text] [Related]
65. Traditional and newer therapeutic options for psoriatic arthritis: an evidence-based review.
Gladman DD
Drugs; 2005; 65(9):1223-38. PubMed ID: 15916449
[TBL] [Abstract][Full Text] [Related]
66. Current and investigational treatment of psoriatic arthritis.
Prasad R; Gladman D
Expert Opin Investig Drugs; 2004 Feb; 13(2):139-50. PubMed ID: 14996648
[TBL] [Abstract][Full Text] [Related]
67. Treating to target in psoriatic arthritis.
Coates LC
Curr Opin Rheumatol; 2015 Mar; 27(2):107-10. PubMed ID: 25603035
[TBL] [Abstract][Full Text] [Related]
68. Treat-to-target in PsA: methods and necessity.
Dures E; Shepperd S; Mukherjee S; Robson J; Vlaev I; Walsh N; Coates LC
RMD Open; 2020 Feb; 6(1):. PubMed ID: 32071281
[TBL] [Abstract][Full Text] [Related]
69. Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management.
Butt AQ; McArdle A; Gibson DS; FitzGerald O; Pennington SR
Curr Rheumatol Rep; 2015 May; 17(5):35. PubMed ID: 25895652
[TBL] [Abstract][Full Text] [Related]
70. [Biological treatment of psoriatic arthritis].
Štolfa J
Vnitr Lek; 2018; 64(2):127-135. PubMed ID: 29595278
[TBL] [Abstract][Full Text] [Related]
71. Treatment strategies for psoriatic arthritis.
Schemoul J; Poulain C; Claudepierre P
Joint Bone Spine; 2018 Oct; 85(5):537-544. PubMed ID: 29155104
[TBL] [Abstract][Full Text] [Related]
72. The diagnosis and treatment of early psoriatic arthritis.
Anandarajah AP; Ritchlin CT
Nat Rev Rheumatol; 2009 Nov; 5(11):634-41. PubMed ID: 19806150
[TBL] [Abstract][Full Text] [Related]
73. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment.
Coates LC; Fransen J; Helliwell PS
Ann Rheum Dis; 2010 Jan; 69(1):48-53. PubMed ID: 19147615
[TBL] [Abstract][Full Text] [Related]
74. Psychologic Morbidity Among Psoriatic Arthritis Patients in Remission or With Low Disease Activity: A Comparison Between Biologic and Conventional Synthetic Disease-Modifying Antirheumatic Drugs.
Wohl Y; Reitblat O; Lerman TT; Cohen O; Reitblat T
J Clin Rheumatol; 2020 Sep; 26(6):260-264. PubMed ID: 31192858
[TBL] [Abstract][Full Text] [Related]
75. Genetic and inflammatory factors associated with psoriatic arthritis: Relevance to diagnosis and management.
Furst DE; Belasco J; Louie JS
Clin Immunol; 2019 May; 202():59-75. PubMed ID: 30738143
[TBL] [Abstract][Full Text] [Related]
76. Can biologic therapies be withdrawn or tapered in psoriatic arthritis?
Moverley AR; Coates LC; Helliwell PS
Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S51-3. PubMed ID: 24129138
[TBL] [Abstract][Full Text] [Related]
77. Assessment and treatment of psoriatic spondylitis.
Nash P
Curr Rheumatol Rep; 2009 Aug; 11(4):278-83. PubMed ID: 19691931
[TBL] [Abstract][Full Text] [Related]
78. The Changing Face of Clinical Trials in Psoriatic Arthritis.
Ogdie A; Coates L
Curr Rheumatol Rep; 2017 Apr; 19(4):21. PubMed ID: 28365920
[TBL] [Abstract][Full Text] [Related]
79. Implementing Psoriatic Arthritis Disease Activity Score-guided treat-to-target in psoriatic arthritis routine clinical practice: (im)possible?
Mulder MLM; den Broeder AA; van Ginneken BTJ; Mahler EAM; van den Hoogen FHJ; Vriezekolk JE; Wenink MH
Rheumatology (Oxford); 2019 Dec; 58(12):2330-2331. PubMed ID: 31230083
[No Abstract] [Full Text] [Related]
80. Current treatments and recommendations for Psoriatic Arthritis.
Vivekanantham A; McGagh D; Coates LC
Best Pract Res Clin Rheumatol; 2021 Jun; 35(2):101680. PubMed ID: 33824068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
